Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Haussmann

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Radiation Oncology (London, England)|July 31, 2024
Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancerJan Haussmann, Wilfried Budach, Carolin Nestle-Krämling, et al.
Frontiers in Immunology|July 27, 2023
Editorial: Immune response to SARS-CoV-2 and implications for clinical outcomeEdwin Bölke, Martijn van Griensven, E Marion Schneider, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 24, 2019
Adjuvant radiochemotherapy vs. chemotherapy alone in gastric cancer: a meta-analysisChristiane Matuschek, Jan Haussmann, Edwin Bölke, et al.
Cancers|March 10, 2022
Post-Neoadjuvant Treatment Strategies in Breast CancerChristiane Matuschek, Danny Jazmati, Edwin Bölke, et al.
Cancers|August 26, 2022
Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast CancerJan Haussmann, Wilfried Budach, Carolin Nestle-Krämling, et al.
Radiation Oncology (London, England)|April 2, 2020
Recent advances in radiotherapy of breast cancerJan Haussmann, Stefanie Corradini, Carolin Nestle-Kraemling, et al.
Cancers|July 27, 2022
Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast IrradiationDanny Jazmati, Edwin Bölke, Kati Halfmann, et al.
Radiation Oncology (London, England)|October 6, 2018
Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysisChristiane Matuschek, Jan Haussmann, Edwin Bölke, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2020
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomideKerstin Berger, Bernd Turowski, Jörg Felsberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 6, 2019
Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysisJan Haussmann, Bálint Tamaskovics, Edwin Bölke, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Radiation Oncology (London, England)|July 31, 2024
Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancerJan Haussmann, Wilfried Budach, Carolin Nestle-Krämling, et al.
Frontiers in Immunology|July 27, 2023
Editorial: Immune response to SARS-CoV-2 and implications for clinical outcomeEdwin Bölke, Martijn van Griensven, E Marion Schneider, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 24, 2019
Adjuvant radiochemotherapy vs. chemotherapy alone in gastric cancer: a meta-analysisChristiane Matuschek, Jan Haussmann, Edwin Bölke, et al.
Cancers|March 10, 2022
Post-Neoadjuvant Treatment Strategies in Breast CancerChristiane Matuschek, Danny Jazmati, Edwin Bölke, et al.
Cancers|August 26, 2022
Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast CancerJan Haussmann, Wilfried Budach, Carolin Nestle-Krämling, et al.
Radiation Oncology (London, England)|April 2, 2020
Recent advances in radiotherapy of breast cancerJan Haussmann, Stefanie Corradini, Carolin Nestle-Kraemling, et al.
Cancers|July 27, 2022
Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast IrradiationDanny Jazmati, Edwin Bölke, Kati Halfmann, et al.
Radiation Oncology (London, England)|October 6, 2018
Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysisChristiane Matuschek, Jan Haussmann, Edwin Bölke, et al.
Journal of Cancer Research and Clinical Oncology|August 5, 2020
Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomideKerstin Berger, Bernd Turowski, Jörg Felsberg, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 6, 2019
Addition of chemotherapy to hyperfractionated radiotherapy in advanced head and neck cancer-a meta-analysisJan Haussmann, Bálint Tamaskovics, Edwin Bölke, et al.
Pageof 4